These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 29410671)
1. Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults. van der Heiden M; de Rond LGH; van Zelm MC; Berbers GAM; Boots AMH; Buisman AM Front Immunol; 2018; 9():46. PubMed ID: 29410671 [TBL] [Abstract][Full Text] [Related]
2. Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults. Weinberg A; Canniff J; Rouphael N; Mehta A; Mulligan M; Whitaker JA; Levin MJ J Immunol; 2017 Jul; 199(2):604-612. PubMed ID: 28607114 [TBL] [Abstract][Full Text] [Related]
3. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination. Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817 [TBL] [Abstract][Full Text] [Related]
4. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity. Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579 [TBL] [Abstract][Full Text] [Related]
5. The inactivated herpes zoster vaccine HZ/su induces a varicella zoster virus specific cellular and humoral immune response in patients on dialysis. Hielscher F; Schmidt T; Enders M; Leyking S; Gerhart M; van Bentum K; Mihm J; Schub D; Sester U; Sester M EBioMedicine; 2024 Oct; 108():105335. PubMed ID: 39265505 [TBL] [Abstract][Full Text] [Related]
6. Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge. Patel NP; Vukmanovic-Stejic M; Suarez-Farinas M; Chambers ES; Sandhu D; Fuentes-Duculan J; Mabbott NA; Rustin MHA; Krueger J; Akbar AN J Infect Dis; 2018 Sep; 218(suppl_2):S88-S98. PubMed ID: 30247603 [TBL] [Abstract][Full Text] [Related]
7. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. Laing KJ; Russell RM; Dong L; Schmid DS; Stern M; Magaret A; Haas JG; Johnston C; Wald A; Koelle DM J Infect Dis; 2015 Oct; 212(7):1022-31. PubMed ID: 25784732 [TBL] [Abstract][Full Text] [Related]
8. Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans. Sullivan NL; Reuter-Monslow MA; Sei J; Durr E; Davis CW; Chang C; McCausland M; Wieland A; Krah D; Rouphael N; Mehta AK; Mulligan MJ; Pulendran B; Ahmed R; Vora KA J Virol; 2018 Jul; 92(14):. PubMed ID: 29743372 [TBL] [Abstract][Full Text] [Related]
9. Identification and Characterization of CD4 Voic H; de Vries RD; Sidney J; Rubiro P; Moore E; Phillips E; Mallal S; Schwan B; Weiskopf D; Sette A; Grifoni A J Virol; 2020 Nov; 94(24):. PubMed ID: 32999027 [TBL] [Abstract][Full Text] [Related]
10. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4 Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406 [TBL] [Abstract][Full Text] [Related]
11. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine. Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581 [TBL] [Abstract][Full Text] [Related]
12. Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women. Perciani CT; Sekhon M; Hundal S; Farah B; Ostrowski MA; Anzala AO; McKinnon LR; Jaoko W; MacDonald KS; J Infect Dis; 2018 Sep; 218(8):1210-1218. PubMed ID: 29800309 [TBL] [Abstract][Full Text] [Related]
13. Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults. Schwarz TF; Volpe S; Catteau G; Chlibek R; David MP; Richardus JH; Lal H; Oostvogels L; Pauksens K; Ravault S; Rombo L; Sonder G; Smetana J; Heineman T; Bastidas A Hum Vaccin Immunother; 2018 Jun; 14(6):1370-1377. PubMed ID: 29461919 [TBL] [Abstract][Full Text] [Related]
14. Serological and T Cell Responses After Varicella Zoster Virus Vaccination in HIV-Positive Patients Undergoing Renal Dialysis. Righi E; Carnelutti A; La Rosa A; Sartor A; Tulissi P; Gallo T; Ivaldi F; Bassetti M Viral Immunol; 2019 Apr; 32(3):151-157. PubMed ID: 30694731 [TBL] [Abstract][Full Text] [Related]
15. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. Perciani CT; Farah B; Kaul R; Ostrowski MA; Mahmud SM; Anzala O; Jaoko W; ; MacDonald KS J Clin Invest; 2019 Feb; 129(2):875-886. PubMed ID: 30511963 [TBL] [Abstract][Full Text] [Related]
16. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial. Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381 [TBL] [Abstract][Full Text] [Related]
17. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Chlibek R; Pauksens K; Rombo L; van Rijckevorsel G; Richardus JH; Plassmann G; Schwarz TF; Catteau G; Lal H; Heineman TC Vaccine; 2016 Feb; 34(6):863-8. PubMed ID: 26432913 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Varicella-zoster virus-specific cell-mediated immunity by interferon-γ Enzyme-Linked Immunosorbent Assay in adults ≥50 years of age administered a herpes zoster vaccine. Yang P; Chen Z; Zhang J; Li W; Zhu C; Qiu P; Quan Y; Cui X; Yuan L; Jiang C J Med Virol; 2019 May; 91(5):829-835. PubMed ID: 30613990 [TBL] [Abstract][Full Text] [Related]
19. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients. van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]